Hiroyuki Shimada
Impact in
- Neurology top 0.02%
- Neuroblastoma Research and Treatments
- Neurofibromatosis and Schwannoma Cases
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
Papers in
- Neurology 181
- Neuroblastoma Research and Treatments 158
- Neurofibromatosis and Schwannoma Cases 20
-
- Cancer therapeutics and mechanisms 13
- Co-authors
- Robert C. Seeger (39 shared papers)Katherine K. Matthay (46 shared papers)Robert B. Gerbing (19 shared papers)Daniel O. Stram (21 shared papers)Yves A. DeClerck (23 shared papers)C. Patrick Reynolds (12 shared papers)Garrett M. Brodeur (12 shared papers)Junichi Hata (8 shared papers)
- Journals
- Cancer (25 papers)Journal of Clinical Oncology (24 papers)Cancer Research (13 papers)Pediatric Blood & Cancer (10 papers)Blood (7 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Hiroyuki Shimada
369 papers receiving 20.6k citations
Hiroyuki Shimada's Hit Papers
Peers
Comparison fields: 5 of 173
- Neurology 9.9k
- Cancer Research 4.1k
- Oncology 3.2k
- Immunology and Allergy 635
- Molecular Biology 7.1k
Countries citing papers authored by Hiroyuki Shimada
This map shows the geographic impact of Hiroyuki Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Shimada more than expected).
Fields of papers citing papers by Hiroyuki Shimada
This network shows the impact of papers produced by Hiroyuki Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Shimada. The network helps show where Hiroyuki Shimada may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroyuki Shimada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 380 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid Hit paper breakdown → | 1999 | 1437 |
| 2 | The International Neuroblastoma Pathology Classification (the Shimada system) Hit paper breakdown → | 1999 | 742 |
| 3 | Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas Hit paper breakdown → | 1984 | 666 |
| 4 | Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study Hit paper breakdown → | 2009 | 630 |
| 5 | 1995 | 482 | |
| 6 | Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. | 1999 | 447 |
| 7 | 1999 | 415 | |
| 8 | 2005 | 406 | |
| 9 | 2005 | 399 | |
| 10 | Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. | 1992 | 375 |
| 11 | 1995 | 357 | |
| 12 | 2008 | 337 | |
| 13 | 2010 | 325 | |
| 14 | 1999 | 316 | |
| 15 | Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy Hit paper breakdown → | 2015 | 296 |
| 16 | Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group Hit paper breakdown → | 2021 | 269 |
| 17 | 2012 | 216 | |
| 18 | 2009 | 208 | |
| 19 | 2001 | 204 | |
| 20 | 2001 | 204 |
About Hiroyuki Shimada
Hiroyuki Shimada is a scholar working on Neurology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Physiology, having authored 380 papers that have together received 21.0k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (158 papers), Alzheimer's disease research and treatments (28 papers), Sarcoma Diagnosis and Treatment (24 papers), Cancer, Hypoxia, and Metabolism (24 papers), Neurofibromatosis and Schwannoma Cases (20 papers), Glioma Diagnosis and Treatment (14 papers), Protease and Inhibitor Mechanisms (13 papers) and Cancer therapeutics and mechanisms (13 papers). The work is most often cited by research in Neurology (9.9k citations), Cancer Research (4.1k citations), Oncology (3.2k citations), Immunology and Allergy (635 citations) and Molecular Biology (7.1k citations). Hiroyuki Shimada has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Robert C. Seeger, Katherine K. Matthay, Robert B. Gerbing, Daniel O. Stram, Yves A. DeClerck, C. Patrick Reynolds, Garrett M. Brodeur, Junichi Hata, Louis P. Dehner and Borghild Roald. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Cancer Research, Pediatric Blood & Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.